Published • loading... • Updated
Publix Q1 earnings decline as drug pricing affects results
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Publix Q1 earnings decline as drug pricing affects results
LAKELAND, Fla. — Publix reported first-quarter 2026 results that reflect mounting pressure on pharmacy revenues from federal drug pricing changes, even as overall sales edged higher.Sales for the quarter ended March 28 rose 2% to $16.1 billion, up from $15.8 billion a year earlier. The increase was tempered by the impact of the Medicare maximum fair price provisions, which took effect on January 1 and reduced prices on select drugs, lowering pha…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
